LMGYX
Price
$35.96
Change
+$0.10 (+0.28%)
Updated
Aug 15 closing price
Net Assets
660.87M
PMAQX
Price
$47.28
Change
-$0.14 (-0.30%)
Updated
Aug 15 closing price
Net Assets
32.48B
Interact to see
Advertisement

LMGYX vs PMAQX

Header iconLMGYX vs PMAQX Comparison
Open Charts LMGYX vs PMAQXBanner chart's image
Lord Abbett Growth Opportunities I
Price$35.96
Change+$0.10 (+0.28%)
VolumeN/A
Net Assets660.87M
Principal MidCap R6
Price$47.28
Change-$0.14 (-0.30%)
VolumeN/A
Net Assets32.48B
LMGYX vs PMAQX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LMGYX vs. PMAQX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMGYX is a Buy and PMAQX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 32.5B vs. LMGYX (661M). PMAQX pays higher dividends than LMGYX: PMAQX (0.19) vs LMGYX (0.00). LMGYX was incepted earlier than PMAQX: LMGYX (27 years) vs PMAQX (9 years). LMGYX (0.90) is less costly to investors than PMAQX (0.59). LMGYX is a more actively managed with annual turnover of: 117.00 vs. PMAQX (10.50). PMAQX has a lower initial minimum investment than LMGYX: PMAQX (0) vs LMGYX (1000000). LMGYX annual gain was more profitable for investors over the last year : 35.70 vs. PMAQX (9.46). PMAQX return over 5 years is better than : 47.52 vs. LMGYX (12.55).
LMGYXPMAQXLMGYX / PMAQX
Total Expense Ratio0.710.59120%
Annual Report Gross Expense Ratio0.900.59153%
Fund Existence27 years9 years-
Gain YTD14.9255.938251%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets661M32.5B2%
Annual Yield % from dividends0.000.19-
Returns for 1 year35.709.46377%
Returns for 3 years40.3031.96126%
Returns for 5 years12.5547.5226%
Returns for 10 years43.44N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FDMT7.260.16
+2.25%
4D Molecular Therapeutics
FVNNU10.54N/A
N/A
Future Vision II Acquisition Corp.
LKFN62.24-0.63
-1.00%
Lakeland Financial Corp
QRVO89.35-1.31
-1.44%
Qorvo
AGAE1.42-0.07
-4.70%
Allied Gaming & Entertainment